We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Metformin to Reduce Heart Failure After Myocardial Infarction (GIPS-III)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01217307
Recruitment Status : Unknown
Verified October 2013 by Chris Lexis, University Medical Centre Groningen.
Recruitment status was:  Active, not recruiting
First Posted : October 8, 2010
Last Update Posted : October 17, 2013
Sponsor:
Collaborator:
Information provided by (Responsible Party):

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Unknown
  Primary Completion Date : October 2013
  Estimated Study Completion Date : May 2015

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 July 31, 2017  
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):